These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33693793)

  • 1. Response to Trimethoprim-Sulfamethoxazole in a Pediatric Hematopoietic Stem Cell Transplant Recipient With Disseminated Toxoplasmosis: A Case Report.
    Khan A; Schwenk HT; Kohlman K; Bertaina A; Cho S; Montoya JG; Contopoulos-Ioannidis D
    J Pediatric Infect Dis Soc; 2021 Aug; 10(6):745-748. PubMed ID: 33693793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients.
    Schwenk HT; Khan A; Kohlman K; Bertaina A; Cho S; Montoya JG; Contopoulos-Ioannidis DG
    Transplant Cell Ther; 2021 Apr; 27(4):292-300. PubMed ID: 33840441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasmosis in non-cardiac solid organ transplant recipients: A case series and review of literature.
    Ramanan P; Scherger S; Benamu E; Bajrovic V; Jackson W; Hage CA; Hakki M; Baddley JW; Abidi MZ
    Transpl Infect Dis; 2020 Feb; 22(1):e13218. PubMed ID: 31769583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.
    Mendorf A; Klyuchnikov E; Langebrake C; Rohde H; Ayuk F; Regier M; Christopeit M; Zabelina T; Bacher A; Stübig T; Wolschke C; Bacher U; Kröger N
    Acta Haematol; 2015; 134(3):146-54. PubMed ID: 25968483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serologic status of Toxoplasma gondii infection in pre- and post-heart transplantation in a pediatric population: A preliminary study.
    Orang E; Sayyahfar S; Mahdavi M; Khanaliha K; Amiri M
    Transpl Infect Dis; 2020 Aug; 22(4):e13339. PubMed ID: 32445414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients.
    Bretagne S; Costa JM; Foulet F; Jabot-Lestang L; Baud-Camus F; Cordonnier C
    Transpl Infect Dis; 2000 Sep; 2(3):127-32. PubMed ID: 11429023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations.
    Gajurel K; Dhakal R; Montoya JG
    Curr Opin Infect Dis; 2015 Aug; 28(4):283-92. PubMed ID: 26098500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxoplasmosis in immunocompromised patients].
    Machala L; Kodym P; Malý M; Geleneky M; Beran O; Jilich D
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):59-65. PubMed ID: 26099608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.
    Cavattoni I; Ayuk F; Zander AR; Zabelina T; Bacher A; Cayroglu E; Knospe V; Illies T; Aepfelbacher M; Richard G; Kröger N; Bacher U
    Leuk Lymphoma; 2010 Aug; 51(8):1530-5. PubMed ID: 20578813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.
    Aerts R; Mehra V; Groll AH; Martino R; Lagrou K; Robin C; Perruccio K; Blijlevens N; Nucci M; Slavin M; Bretagne S; Cordonnier C;
    Lancet Infect Dis; 2024 May; 24(5):e291-e306. PubMed ID: 38134949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective study of the implementation of the qualitative PCR technique in biological samples for monitoring toxoplasmosis in pediatric patients receiving hematopoietic stem cell transplantation].
    Nigro MG; Figueroa C; Ledesma BA
    Rev Argent Microbiol; 2014; 46(1):24-9. PubMed ID: 24721270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis.
    Gourishankar S; Doucette K; Fenton J; Purych D; Kowalewska-Grochowska K; Preiksaitis J
    Transplantation; 2008 Apr; 85(7):980-5. PubMed ID: 18408578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasmosis as an Early Complication of Allogeneic Hematopoietic Cell Transplantation.
    Robin C; Leclerc M; Angebault C; Redjoul R; Beckerich F; Cabanne L; Foulet F; Pautas C; Toma A; Maury S; Botterel F; Cordonnier C
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2510-2513. PubMed ID: 31381996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Molina A; Winston DJ; Pan D; Schiller GJ
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1715-1720. PubMed ID: 29555315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebral toxoplasmosis developed after unrelated bone marrow transplantation for acute myeloid leukemia].
    Hirate T; Kitazawa H; Sakaguchi H; Akita N; Hasegawa C; Yamamoto K; Kutsuna S; Mikita K; Mori T; Hama A; Yoshida N
    Rinsho Ketsueki; 2023; 64(10):1275-1279. PubMed ID: 37914240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
    Bell TL; Foster JN; Townsend ML
    Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic Next-generation Sequencing May be a Tool for Timely Diagnosis of Seronegative and Primary Toxoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review.
    Lv Q; Cao Y; Wang J; Meng L; Wang G
    Pediatr Infect Dis J; 2024 Feb; 43(2):155-159. PubMed ID: 38190489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole-induced rhabdomyolysis in an allogeneic stem cell transplant patient.
    Kiel PJ; Dickmeyer N; Schwartz JE
    Transpl Infect Dis; 2010 Oct; 12(5):451-4. PubMed ID: 20561303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis.
    Patrat-Delon S; Gangneux JP; Lavoué S; Lelong B; Guiguen C; le Tulzo Y; Robert-Gangneux F
    J Clin Microbiol; 2010 Jul; 48(7):2541-5. PubMed ID: 20463167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.